Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F1G08
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,036
Award facts
- Contract value 100% obligated
- $29,035.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Dupixent 300 mg/2 ml pen auto-injectors, with a ceiling value of $29,035.64 and a completion date of November 7, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, representing a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
Dupixent (dupilumab) is a biologic immunosuppressant medication used to treat atopic dermatitis, eosinophilic esophagitis, and other inflammatory conditions. This delivery order supports the Department of Defense's medical supply needs for military personnel and beneficiaries through AmerisourceBergen's role as a pharmaceutical prime vendor. AmerisourceBergen's comprehensive IDC with DLA enables the company to supply a broad range of brand-name and generic pharmaceuticals, specialty medications, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26F1G08?
SPE2DR26F1G08 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26F1G08 worth?
The government has obligated $29,036 on SPE2DR26F1G08.
Is contract SPE2DR26F1G08 an order under another contract?
Yes. SPE2DR26F1G08 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1G08 competed?
The extent of competition for SPE2DR26F1G08 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award